US health regulators probe Theranos over inaccurate blood-testing device
Blood testing company, Theranos, is under scrutiny for their inaccurate blood testing device. The $9 billion startup company, Theranos Inc, is under investigation by the Food and Drug Administration after complaints from former employees regarding the company's inaccurate blood testing device.